Trials / Completed
CompletedNCT01838031
Thyroid Screening Protocol During Pregnancy: a Multi-center Prospective Controlled Study
Randomized Thyroid Screening Protocol During Pregnancy: a Multi-center Prospective Controlled Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,000 (estimated)
- Sponsor
- Peking Union Medical College Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 42 Years
- Healthy volunteers
- Not accepted
Summary
Estimate the proper thyroid screening method during pregnancy. Evaluate if maternal subclinical hypothyroidism treatment during pregnancy result in improved pregnancy outcome and cognitive function in the children.
Detailed description
The investigators conducted a single-blinded trial in which pregnant women at a gestation of less than 12 weeks, usually 6 to 8 weeks, provided blood samples for measurement of thyrotropin, free thyroxine(FT4) and thyroid peroxidase antibody (TPOAb). Women were assigned to a screening group in PUMCH (in which measurements were obtained immediately) or a control group in HMCHH (in which serum was stored and measurements were obtained shortly after delivery). Each group enrolled 1000 pregnant women separately. Women with positive findings in the screening group were given individualized levothyroxine treatment and regular follow-up. Compare the pregnancy outcomes, IQ at 2-3 years of age in children of women with subclinical hypothyroidism between two groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | thyroid screening | The thyroid function and antibody will be measured immediately. The subclinical hypothyroidism will be treated individually. |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2013-09-01
- Completion
- 2013-09-01
- First posted
- 2013-04-23
- Last updated
- 2013-11-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01838031. Inclusion in this directory is not an endorsement.